12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's pre-market session, several healthcare stocks experienced significant price movements. CNS Pharma, DBV Technologies, and Cyclacel Pharmaceuticals saw substantial gains, while Alto Neuroscience and Ensysce Biosciences faced notable declines.
October 23, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Alto Neuroscience's stock plummeted by 62.3% in pre-market trading.
The significant drop in Alto Neuroscience's stock price indicates negative news or sentiment, likely leading to short-term losses.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Ensysce Biosciences' stock fell by 18.58% in pre-market trading.
The decline in Ensysce Biosciences' stock price suggests negative developments or sentiment, likely leading to short-term losses.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
CNS Pharma's stock surged by 143.7% in pre-market trading, indicating strong investor interest.
The significant increase in CNS Pharma's stock price suggests positive news or investor sentiment, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Cyclacel Pharmaceuticals' stock rose by 46.15% in pre-market trading.
The increase in Cyclacel Pharmaceuticals' stock price suggests positive developments or investor sentiment, likely leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
DBV Technologies saw a 62.87% increase in its stock price during pre-market trading.
The sharp rise in DBV Technologies' stock price indicates a positive market reaction, suggesting potential short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100